214
Views
48
CrossRef citations to date
0
Altmetric
Original Article

Diffuse Large B-cell Lymphoma Arising in Nodular Lymphocyte Predominant Hodgkin Lymphoma: a Report of 21 Cases from the Nebraska Lymphoma Study Group

, , , , , , , & show all
Pages 1551-1557 | Received 10 May 2003, Published online: 26 Aug 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Tanuja Shet, Poonam Panjwani, Sridhar Epari, Manju Sengar, Maya Prasad, Brijesh Arora, Siddhartha Laskar, Sumeet Gujral, Hari Menon & Shripad Banavali. (2015) A simplified scoring system to document variant patterns in nodular lymphocyte predominant Hodgkin lymphoma. Leukemia & Lymphoma 56:6, pages 1651-1658.
Read now
Eliza A. Hawkes, Andrew Wotherspoon & David Cunningham. (2012) The unique entity of nodular lymphocyte-predominant Hodgkin lymphoma: current approaches to diagnosis and management. Leukemia & Lymphoma 53:3, pages 354-361.
Read now

Articles from other publishers (46)

C. Rénard, L. Claude, N. Garnier & M. Penel-Page. (2022) Linfoma de Hodgkin en niños y adolescentes. EMC - Pediatría 57:2, pages 1-14.
Crossref
Sibrandes Poppema. (2020) Lymphocyte predominant Hodgkin lymphoma, antigen‐driven after all? . The Journal of Pathology 253:1, pages 1-10.
Crossref
Sylvia Hartmann & Dennis A. Eichenauer. (2020) Nodular lymphocyte predominant Hodgkin lymphoma: pathology, clinical course and relation to T-cell/histiocyte rich large B-cell lymphoma. Pathology 52:1, pages 142-153.
Crossref
Hao-Wei Wang, Jayalakshmi P. Balakrishna, Stefania Pittaluga & Elaine S. Jaffe. (2019) Diagnosis of Hodgkin lymphoma in the modern era. British Journal of Haematology 184:1, pages 45-59.
Crossref
Mamatha Siricilla, Lydia Irwin & Andres Ferber. (2018) A Case of Chemotherapy-Refractory “THRLBCL like Transformation of NLPHL” Successfully Treated with Lenalidomide. Case Reports in Oncological Medicine 2018, pages 1-8.
Crossref
Sylvia Hartmann & Martin-Leo Hansmann. 2018. Precision Molecular Pathology of Hodgkin Lymphoma. Precision Molecular Pathology of Hodgkin Lymphoma 111 125 .
Jonathan R. Fromm, Anju Thomas & Brent L. Wood. (2017) Characterization and Purification of Neoplastic Cells of Nodular Lymphocyte Predominant Hodgkin Lymphoma from Lymph Nodes by Flow Cytometry and Flow Cytometric Cell Sorting. The American Journal of Pathology 187:2, pages 304-317.
Crossref
S. Hartmann & M.-L. Hansmann. (2016) Update zum nodulären lymphozytenprädominanten Hodgkin-Lymphom und verwandten LäsionenUpdate on nodular lymphocyte predominant Hodgkin’s lymphoma and related lesions. Der Pathologe 38:1, pages 3-10.
Crossref
Bianca Schuhmacher, Benjamin Rengstl, Claudia Döring, Julia Bein, Sebastian Newrzela, Uta Brunnberg, Hans Michael Kvasnicka, Martine Vornanen, Ralf Küppers, Martin-Leo Hansmann & Sylvia Hartmann. (2016) A strong host response and lack of MYC expression are characteristic for diffuse large B cell lymphoma transformed from nodular lymphocyte predominant Hodgkin lymphoma. Oncotarget 7:44, pages 72197-72210.
Crossref
Burton E. AppelLu ChenAllen B. BuxtonRobert E. HutchisonDavid C. HodgsonPeter F. EhrlichLouis S. ConstineCindy L. Schwartz. (2016) Minimal Treatment of Low-Risk, Pediatric Lymphocyte-Predominant Hodgkin Lymphoma: A Report From the Children's Oncology Group. Journal of Clinical Oncology 34:20, pages 2372-2379.
Crossref
Ananth G. Shankar, Amy A. Kirkwood, Sarita Depani, Eleonora Bianchi, Janis Hayward, Alan D. Ramsay & Georgina W. Hall. (2016) Relapsed or poorly responsive nodular lymphocyte predominant Hodgkin lymphoma in children and adolescents - a report from the United Kingdom's Children's Cancer and Leukaemia Study Group. British Journal of Haematology 173:3, pages 421-431.
Crossref
Saad Sirop Kenderian, Thomas M. HabermannWilliam R. Macon, Kay M. RistowStephen M. AnsellJoseph P. ColganPatrick B. JohnstonDavid J. InwardsSvetomir N. MarkovicIvana N. MicallefCarrie A. ThompsonLuis F. PorrataJames A. Martenson, Thomas E. WitzigGrzegorz S. Nowakowski. (2016) Large B-cell transformation in nodular lymphocyte-predominant Hodgkin lymphoma: 40-year experience from a single institution. Blood 127:16, pages 1960-1966.
Crossref
Dimitra S. Anagnostou. 2016. PET/CT in Lymphomas. PET/CT in Lymphomas 3 19 .
Ahmed E. Eladl, Akira Satou, Ahmed Ali Elsayed, Yuka Suzuki, Kei Shimizu‐Kohno, Seiichi Kato, Akihiro Tomita, Tomohiro Kinoshita, Shigeo Nakamura & Naoko Asano. (2015) Nodular lymphocyte predominant Hodgkin lymphoma: Clincopathological study of 25 cases from J apan with a reappraisal of tissue associated macrophages . Pathology International 65:12, pages 652-660.
Crossref
Antonino Carbone & Anas YounesMaria Costanza Aquilano & Antonino Carbone. 2015. Hodgkin And Non-Hodgkin Lymphomas Seen Through Their Microenvironment: Impact on Diagnosis, Prognosis and Innovative Therapy (Volume 2). Hodgkin And Non-Hodgkin Lymphomas Seen Through Their Microenvironment: Impact on Diagnosis, Prognosis and Innovative Therapy (Volume 2) 2 19 .
Antonino Carbone & Anas Younes. 2015. Hodgkin And Non-Hodgkin Lymphomas Seen Through Their Microenvironment: Impact on Diagnosis, Prognosis and Innovative Therapy (Volume 2). Hodgkin And Non-Hodgkin Lymphomas Seen Through Their Microenvironment: Impact on Diagnosis, Prognosis and Innovative Therapy (Volume 2).
Toby A. Eyre, Kevin Gatter, Graham P. Collins, Georgina W. Hall, Caroline Watson & Chris S.R. Hatton. (2015) Incidence, management, and outcome of high-grade transformation of nodular lymphocyte predominant hodgkin lymphoma: Long-term outcomes from a 30-year experience. American Journal of Hematology 90:6, pages E103-E110.
Crossref
Sylvia Hartmann, Mine Eray, Claudia Döring, Tuula Lehtinen, Uta Brunnberg, Paula Kujala, Martine Vornanen & Martin-Leo Hansmann. (2014) Diffuse large B cell lymphoma derived from nodular lymphocyte predominant Hodgkin lymphoma presents with variable histopathology. BMC Cancer 14:1.
Crossref
C. Rénard-Loche, M. Schell, L. Claude & Y. Bertrand. (2014) Linfoma de Hodgkin del niño y del adolescente. EMC - Pediatría 49:4, pages 1-12.
Crossref
Anupama Goel, Wen Fan, Amit A. Patel, Madhuri Devabhaktuni & Michael L. Grossbard. (2014) Nodular Lymphocyte Predominant Hodgkin Lymphoma: Biology, Diagnosis and Treatment. Clinical Lymphoma Myeloma and Leukemia 14:4, pages 261-270.
Crossref
Yi-Hua Chen & Yun Gong. 2014. Cytopathology in Oncology. Cytopathology in Oncology 211 240 .
Ranjana H. Advani & Richard T. Hoppe. (2013) How I treat nodular lymphocyte predominant Hodgkin lymphoma. Blood 122:26, pages 4182-4188.
Crossref
Katharine H. Xing & Kerry J. Savage. (2013) Modern management of lymphocyte predominant Hodgkin lymphoma. British Journal of Haematology 161:3, pages 316-329.
Crossref
燕 张. (2013) The Diagnosis and Differential Diagnosis of Nodular Lymphocyte Predominant Hodgkin Lymphoma(NLPHL). Advances in Clinical Medicine 03:04, pages 33-36.
Crossref
Kenneth R. Carson & Nancy L. Bartlett. 2013. Patient Surveillance After Cancer Treatment. Patient Surveillance After Cancer Treatment 461 466 .
Burton E. Appel, Lu Chen, Allen Buxton, Suzanne L. Wolden, David C. Hodgson & James B. Nachman. (2012) Impact of low‐dose involved‐field radiation therapy on pediatric patients with lymphocyte‐predominant Hodgkin lymphoma treated with chemotherapy: A report from the Children's Oncology Group. Pediatric Blood & Cancer 59:7, pages 1284-1289.
Crossref
Ananth Shankar & Stephen Daw. (2012) Nodular lymphocyte predominant H odgkin lymphoma in children and adolescents – a comprehensive review of biology, clinical course and treatment options . British Journal of Haematology 159:3, pages 288-298.
Crossref
Ananth Shankar, Georgina W. Hall, Stephanie Gorde-Grosjean, Dirk Hasenclever, Thierry Leblanc, Janis Hayward, Anne Lambilliotte, Stephen Daw, Yves Perel, Keith McCarthy, Odile Lejars, Aurore Coulomb, W. Odile Oberlin, W. Hamish Wallace & Judith Landman-Parker. (2012) Treatment outcome after low intensity chemotherapy [CVP] in children and adolescents with early stage nodular lymphocyte predominant Hodgkin’s lymphoma – An Anglo-French collaborative report. European Journal of Cancer 48:11, pages 1700-1706.
Crossref
Claudiu V Cotta, Joshua F Coleman, Shiyong Li & Eric D Hsi. (2011) Nodular lymphocyte predominant Hodgkin lymphoma and diffuse large B-cell lymphoma: a study of six cases concurrently involving the same site. Histopathology 59:6, pages 1194-1203.
Crossref
Marnelli A. Bautista-Quach, Antranik Bedros & Jun Wang. (2011) Subsequent Development of Diffuse Large B-cell Lymphomas and Hodgkin Lymphoma Associated With Primary Immune Disorder in a 6-year-old Female. Journal of Pediatric Hematology/Oncology 33:7, pages e320-e325.
Crossref
Çiğdem Atayar & Sibrand Poppema. 2011. Hematopathology. Hematopathology 436 453 .
Andreas Engert & Anas Younes. 2011. Hodgkin Lymphoma. Hodgkin Lymphoma 229 239 .
Lauren B. Smith. (2010) Nodular Lymphocyte Predominant Hodgkin Lymphoma: Diagnostic Pearls and Pitfalls. Archives of Pathology & Laboratory Medicine 134:10, pages 1434-1439.
Crossref
Izhar N. Bagwan, Graham Knee, Zaid Abboudi & Kikkeri N. Naresh. (2010) Small intestinal presentation of nodular lymphocyte-predominant Hodgkin lymphoma with T cell/histiocyte-rich B cell lymphoma-like areas—with review of literature on extranodal presentation of this disease. Journal of Hematopathology 3:1, pages 29-34.
Crossref
Mubarak Al-MansourJoseph M. ConnorsRandy D. GascoyneBrian SkinniderKerry J. Savage. (2010) Transformation to Aggressive Lymphoma in Nodular Lymphocyte-Predominant Hodgkin's Lymphoma. Journal of Clinical Oncology 28:5, pages 793-799.
Crossref
Haresh Mani & Elaine S. Jaffe. (2009) Hodgkin Lymphoma: An Update on Its Biology With New Insights Into Classification. Clinical Cancer Reviews 3:1, pages 54-64.
Crossref
Bertram Schnitzer. (2009) Hodgkin Lymphoma. Hematology/Oncology Clinics of North America 23:4, pages 747-768.
Crossref
Haresh Mani & Elaine S. Jaffe. (2009) Hodgkin Lymphoma: An Update on its Biology with New Insights into Classification. Clinical Lymphoma and Myeloma 9:3, pages 206-216.
Crossref
Jia-Hong Chen, Wen-Chiuan Tsai & Ching-Liang Ho. (2009) Secondary nodal marginal zone B cell lymphoma arising in primary mixed cellularity subtype of Hodgkin’s lymphoma. Annals of Hematology 88:5, pages 501-503.
Crossref
Joseph M. Connors. (2009) Clinical Manifestations and Natural History of Hodgkin’s Lymphoma. The Cancer Journal 15:2, pages 124-128.
Crossref
Franziska C. Eberle, Haresh Mani & Elaine S. Jaffe. (2009) Histopathology of Hodgkin’s Lymphoma. The Cancer Journal 15:2, pages 129-137.
Crossref
KAREN L. CHANG, DANIEL A. ARBER & LAWRENCE M. WEISS. 2009. Modern Surgical Pathology. Modern Surgical Pathology 1431 1511 .
Á. Illés, Zs Simon, E. Tóth, A. Rosta, Zs Miltényi & Zs Molnár. (2008) Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL)—Clinicopathological Features Based on the Data of Two Hungarian Lymphoma Centres. Pathology & Oncology Research 14:4, pages 411-421.
Crossref
G. W. Hall, N. Katzilakis, C. R. Pinkerton, G. Nicolin, S. Ashley, Keith McCarthy, S. Daw, M. Hewitt, W. H. Wallace & A. Shankar. (2007) Outcome of children with nodular lymphocyte predominant Hodgkin lymphoma - a Children's Cancer and Leukaemia Group report. British Journal of Haematology 138:6, pages 761-768.
Crossref
Lucia Nogová, Thomas Rudiger & Andreas Engert. (2006) Biology, Clinical Course and Management of Nodular Lymphocyte-Predominant Hodgkin Lymphoma. Hematology 2006:1, pages 266-272.
Crossref
. 2006. The Lymphomas. The Lymphomas 476 499 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.